341 related articles for article (PubMed ID: 28914715)
61. The incidence of mTOR marker in tracheal adenoid cystic carcinoma by immunohistochemical staining.
Pourabdollah Toutkaboni M; Farahani M; Sadegh A; Kiani A; Sadr M; Taghavi K; Abedini A
Adv Respir Med; 2020; 88(4):305-312. PubMed ID: 32869263
[TBL] [Abstract][Full Text] [Related]
62. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers.
Darling MR; Schneider JW; Phillips VM
Oral Oncol; 2002 Oct; 38(7):641-5. PubMed ID: 12167416
[TBL] [Abstract][Full Text] [Related]
63. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
[TBL] [Abstract][Full Text] [Related]
64. Sodium Iodide Symporter Expression in Adenoid Cystic Carcinoma of the Head and Neck.
Gainor DL; Chute DJ; Lorenz RR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):739-44. PubMed ID: 26043070
[TBL] [Abstract][Full Text] [Related]
65. Immunohistochemical expression of CA19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland.
Okamura K; Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Ishibashi H; Komatsu S; Rasul AM; Sakai H
Oral Oncol; 2002 Apr; 38(3):244-50. PubMed ID: 11978546
[TBL] [Abstract][Full Text] [Related]
66. The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands.
Zhang ZY; Wu YQ; Zhang WG; Tian Z; Cao J
Chin J Dent Res; 2000 Nov; 3(3):36-9. PubMed ID: 11314533
[TBL] [Abstract][Full Text] [Related]
67. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
[TBL] [Abstract][Full Text] [Related]
68. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.
Liu B; Mitani Y; Rao X; Zafereo M; Zhang J; Zhang J; Futreal PA; Lozano G; El-Naggar AK
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117356
[TBL] [Abstract][Full Text] [Related]
69. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis.
Freier K; Flechtenmacher C; Walch A; Ohl S; Devens F; Burke B; Hassfeld S; Lichter P; Joos S; Hofele C
Cancer Genet Cytogenet; 2005 May; 159(1):89-95. PubMed ID: 15860365
[TBL] [Abstract][Full Text] [Related]
70. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
[TBL] [Abstract][Full Text] [Related]
71. A comparative immunohistochemical study of adenoid cystic carcinoma of the skin and salivary glands.
Bergman R; Lichtig C; Moscona RA; Friedman-Birnbaum R
Am J Dermatopathol; 1991 Apr; 13(2):162-8. PubMed ID: 1709341
[TBL] [Abstract][Full Text] [Related]
72. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
[TBL] [Abstract][Full Text] [Related]
73. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.
Ho AS; Ochoa A; Jayakumaran G; Zehir A; Valero Mayor C; Tepe J; Makarov V; Dalin MG; He J; Bailey M; Montesion M; Ross JS; Miller VA; Chan L; Ganly I; Dogan S; Katabi N; Tsipouras P; Ha P; Agrawal N; Solit DB; Futreal PA; El Naggar AK; Reis-Filho JS; Weigelt B; Ho AL; Schultz N; Chan TA; Morris LG
J Clin Invest; 2019 Oct; 129(10):4276-4289. PubMed ID: 31483290
[TBL] [Abstract][Full Text] [Related]
74. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
Xia R; Zhou R; Tian Z; Zhang C; Wang L; Hu Y; Han J; Li J
Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
[TBL] [Abstract][Full Text] [Related]
75. Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.
Sung JY; Ahn HK; Kwon JE; Jeong H; Baek CH; Son YI; Ahn YC; Park K; Ahn MJ; Ko YH
J Oral Pathol Med; 2012 May; 41(5):415-23. PubMed ID: 22077630
[TBL] [Abstract][Full Text] [Related]
76. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
77. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
[TBL] [Abstract][Full Text] [Related]
78. Correlation of histopathological variants, cellular DNA content, and clinical outcome in adenoid cystic carcinoma of the salivary glands.
Enamorado I; Lakhani R; Korkmaz H; Yoo GH; Del Mar Alonso M; Pietraszkiewicz H; Maciorowski Z; Kim H; Kucuk O; Jacobs JR; Ensley JF
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):646-50. PubMed ID: 15523442
[TBL] [Abstract][Full Text] [Related]
79. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
80. Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.
Vila L; Liu H; Al-Quran SZ; Coco DP; Dong HJ; Liu C
Mod Pathol; 2009 Oct; 22(10):1296-302. PubMed ID: 19617878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
